The Food and Drug Administration today authorized for emergency use the first serology test to help identify individuals with antibodies to SARS-CoV-2 at the point of care.

The agency previously authorized the test for use by certain labs. 

“Until today, serology test samples were generally only able to be evaluated in a central lab, which can be time consuming and use additional resources to transport samples and run the test,” noted FDA Commissioner Stephen Hahn, M.D.
 

Related News Articles

Headline
The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient…
Headline
The Centers for Medicare & Medicaid Services yesterday announced an interim final rule establishing additional Medicare hospital payment to support…
Headline
In partnership with the AHA’s Center for Health Innovation and other national health care organizations, the Centers for Disease Control and Prevention today…
Headline
The Food and Drug Administration yesterday released an updated template for developers requesting emergency use authorization for antigen tests for…
Headline
According to an analysis of COVID-19 hospitalization data from 13 states, released today by the Centers for Disease Control and Prevention, 6% of adults…
Headline
The Food and Drug Administration yesterday approved Veklury (remdesivir) to treat COVID-19 patients age 12 and older who are hospitalized and weigh…